MarketCapTrends
AYTU

Aytu BioPharma Inc. (AYTU)

NASDAQ · Healthcare

Aytu BioPharma Inc. annual/quarterly total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Aytu BioPharma Inc. total liabilities for the quarter ending June 30, 2025 were 105.2M, a 16.41% increase year-over-year.
  • Aytu BioPharma Inc. total liabilities for 2025 were 105.2M, a 16.41% increase from 2024.
  • Aytu BioPharma Inc. total liabilities for 2024 were 90.4M, a 6.93% decrease from 2023.
  • Aytu BioPharma Inc. total liabilities for 2023 were 97.1M, a 4.06% increase from 2022.
  • Aytu BioPharma Inc. total liabilities for 2022 were 93.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Aytu BioPharma Inc. Annual Total Liabilities (Millions of US $)
2025$105
2024$90
2023$97
2022$93
2021$128
2020$58
2019$28
2018$8
2017$11
2016$14
2015$3
2014$7
Aytu BioPharma Inc. Quarterly Total Liabilities (Millions of US $)
2025-06-30$105
2024-06-30$90
2023-06-30$97
2022-06-30$93
2021-06-30$128
2020-06-30$58
2019-06-30$28
2018-06-30$8
2017-06-30$11
2016-06-30$14
2015-06-30$3
2014-06-30$7

Aytu BioPharma Inc. Total Liabilities — FAQ

Aytu BioPharma Inc. (AYTU) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AYTU's total liabilities history?

The chart and table above show Aytu BioPharma Inc.'s total liabilities by year and by quarter, including the growth rate.